The whole Zolpimist thing has me somewhat perplexed. It's been on sale in the US for a while now, if successful, surely the prescription data alone would be enough to entice/close a deal. Would like to know prescription/sales data from the States... At least that would give an indication if there was something substantial heading Suda's way or if we are simply chasing a mirage...
The whole Zolpimist thing has me somewhat perplexed. It's been...
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
-0.005(2.63%) |
Mkt cap ! $195.9M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 17.5¢ | $500.5K | 2.717M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 209104 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 279863 | 4 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| ALA (ASX) Chart |